Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 2, 1996, Pages 189-194

  Bousquet, Jean ^a   Aubert, Bernard ^b   Bons, Jacques ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b Laboratoires Glaxo   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; SALMETEROL;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHITIS; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHONIA; EPIGASTRIC PAIN; FEMALE; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LARYNGITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TREMOR;

EID: 13344269021     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63421-7     Document Type: Article

References (39)

1. Ullman A, Svedmyr N. Inhaled salmeterol - A new β2-adrenoreceptor agonist produced sustained bronchodilation in asthmatic patients without causing tachyphylaxis [Abstract]. Am Rev Respir Dis 1988;137(4: part 2):32.
2. 2-adrenoreceptor: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-8.
3. Britton MG, Earnshaw JS, Palmer JBD. A twelve-month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992;5: 1062-7.
4. Faurschou P. Chronic dose-ranging studies with salmeterol. Eur Resp Rev 1991;1:282-7.
5. Lundback B, Rawlinson DW, Palmer JBD. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. Thorax 1993;48:148-53.
6. Palmer JBD, Hyland ME. Salmeterol in clinical practice: comparator and safety studies, quality of life studies. Eur Respir Rev 1991;1:301-3.
7. Palmer KBD, Stuart AM, Shephard GL, Viskum K. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease - a 3 months comparison of the efficacy and safety of twice daily salmeterol (100 μg) with salmeterol (50 μg). Respir Med 1992;86:409-17.
8. Pearlman DS, Chervinsky P, LaForce C, Selzer JM, et al. A comparison of salmeterol with albuterol in the treatment of mild to moderate asthma. N Engl J Med 1992;327:1420-5.
9. Jones KP. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. Thorax 1994;49: 971-5.
10. Muir JF, Bertin L, Georges D. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicenter trial. Eur Respir J 1992;5:1197-200.
11. Douglas NJ, Fitzpatrick MF. Effects of salmeterol on nocturnal asthma. Eur Respir Rev 1991;1:293-6.
12. 2-agonist. Br Med J 1990;301:1365-8.
13. Newnham DM, Ingram CG, Earnshaw J, Palmer JBD, et al. Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma. Respir Med 1993;87:439-44.
14. 2-agonist has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction. J Allergy Clin Immunol 1992;89:567-74.
15. Nowak D, Jörres R, Rabe KF, et al. Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours. Eur J Clin Pharmacol 1992;43:591-5.
16. Greening AP, Ind PW. Comparison of addition of salmeterol with increase in inhaled steroids in adult asthmatics symptomatic on 200 micrograms bd inhaled steroids. Lancet 1994;344: 219-24.
17. Woolcock A, Lundback B, Ringdal OLN, Jaques LA. Comparison of the effect of addition of salmeterol with doubling the inhaled steroid dose in asthmatic patients [Abstract]. Am J Respir Crit Care Med 1994;149:A280.
18. Foreman JC, Pearce FL. Cromolyn. In: Middleton E Jr, Reed CE, Ellis EF, eds. Allergy, principles and practice, 3rd ed. St Louis: Mosby Co, 1989; 766-81.
19. Shapiro GG, Konig P. Cromolyn sodium. Drugs in perspective. 1985;5: 156-70.
20. Turner-Warwick M, Batten JC. Long-term study of disodium cromoglycate in the treatment of severe extrinsic or intrinsic bronchial asthma. Br Med J 1972;4:383-8.
21. Petty TL, Rollins DR, Christopher K, et al. Cromolyn sodium is effective in adult chronic asthmatics. Am Rev Respir Dis 1989;139:694-701.
22. Eigen H, Reid JJ, Dahl R, et al. Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma. J Allergy Clin Immunol 1987;80:612-21.
23. Guidelines on the management of asthma. Thorax 1993;48(Suppl): S1-S24.
24. American Thoracic Society. Definitions and classifications of chronic bronchitis, asthma and emphysema. Am Rev Respir Dis 1962;85:762-8.
25. Cara M, Hentz P. Aide-mémoire of spirographic practice for examining ventilatory function, 2nd edition. Commission of the European Communities, Luxembourg, Industrial Health and Medicine, series No. 11, 1971.
26. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992;22(Suppl): 1-72.
27. 2-agonists in the treatment of asthma? Chest 1995;107:1116-24.
28. 2-agonists. Drugs 1994;47(2): 207-22.
29. Sears MR, Taylor DR, Print CG, Lake DC, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
30. Van Schayk CP, Dompeling E, van Herwaarden CLA, et al. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. Br Med J 1991;303:1426-31.
31. Harvey JF, Tattersfield AE. Airway response to salbutamol; effect of regular salbutamol inhalations in normal, atopic and asthmatic subjects. Thorax 1982;37:280-7.
32. 2-agonists in the management of asthma. Drug Safety 1992;7: 54-70.
33. 2-agonists and the risk of death and near death from asthma. N Engl J Med 1992;326:501-6.
34. Lenney W, Pedersen S, Boner AL, et al. Efficacy and safety of salmeterol in childhood asthma. Eur J Pediatr 1995; 154:983-90.
35. Boldy DAR, Ayres JG. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. Respir Med 1993;87:517-23.
36. Dahl R, Lundback B, Malo J-L, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-8.
37. Toogood JH, Lefcoe NM, Jennings B, et al. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 59:298-308.
38. Boe J, Rosenhall L, Alton M, et al. Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma. Allergy 1989;44: 349-55.
39. Gaddie J, Reid IW, Skinner C, et al. Aerosol beclomethasone dipropionate: a dose response study in chronic bronchial asthma. Lancet 1973;2:280-1.